{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:20:06Z","timestamp":1788985206677,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03516-1","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:16:05Z","timestamp":1788977765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spray Freeze Drying for Solid Formulations of RNA Lipid Nanoparticles"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4392-4895","authenticated-orcid":false,"given":"Kinnari Santosh","family":"Arte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5612-5804","authenticated-orcid":false,"given":"Rachana","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5070-8920","authenticated-orcid":false,"given":"Chanakya D.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1583-5767","authenticated-orcid":false,"given":"Yijing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8154-6360","authenticated-orcid":false,"given":"Eric J.","family":"Munson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Payton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4107-3671","authenticated-orcid":false,"given":"Rushit","family":"Lodaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-6990","authenticated-orcid":false,"given":"Qi Tony","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4543-3914","authenticated-orcid":false,"given":"Li Lily","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"3516_CR1","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker L, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 2021;601:120586.","journal-title":"Int J Pharm"},{"issue":"2","key":"3516_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.xphs.2024.12.013","volume":"114","author":"KS Arte","year":"2025","unstructured":"Arte KS, et al. Recent advances in drying and development of solid formulations for stable mRNA and siRNA lipid nanoparticles. J Pharm Sci. 2025;114(2):805\u201315.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3516_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.xphs.2022.11.001","volume":"112","author":"EO Blenke","year":"2023","unstructured":"Blenke EO, et al. The storage and in-use stability of mRNA vaccines and therapeutics: not a cold case. J Pharm Sci. 2023;112(2):386\u2013403.","journal-title":"J Pharm Sci"},{"key":"3516_CR4","unstructured":"Das R. Update on Moderna's RSV vaccine, mRESVIA (mRNA-1345), in adults \u226560 years of age [Conference presentation]. Atlanta, GA, United States: Advisory Committee on Immunization Practices Meeting; 2024. https:\/\/stacks.cdc.gov\/view\/cdc\/157864."},{"key":"3516_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2023.03.039","volume":"357","author":"S Meulewaeter","year":"2023","unstructured":"Meulewaeter S, et al. Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures. J Control Release. 2023;357:149\u201360.","journal-title":"J Control Release"},{"key":"3516_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-12-821683-5.00017-0","volume-title":"Microencapsulation in the food industry","author":"JP Szczap","year":"2023","unstructured":"Szczap JP, Jacobs IC. Atomization and spray drying processes. In: Microencapsulation in the food industry. Elsevier; 2023. p. 59\u201371."},{"key":"3516_CR7","unstructured":"Bhatnagar BS, Darvari R, Sebastiao IB, Tchessalov S. Use of a spray freeze-drying process for the lyophilization of a mrna-encapsulating lipid nanoparticles formulation. U.S. Patent Application No. 18\/875,885. 2026."},{"key":"3516_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejpb.2023.11.007","volume":"193","author":"CM Zimmermann","year":"2023","unstructured":"Zimmermann CM, et al. Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying. Eur J Pharm Biopharm. 2023;193:218\u201326.","journal-title":"Eur J Pharm Biopharm"},{"key":"3516_CR9","doi-asserted-by":"publisher","first-page":"123757","DOI":"10.1016\/j.ijpharm.2023.123757","volume":"651","author":"K AboulFotouh","year":"2024","unstructured":"AboulFotouh K, et al. Inhalable dry powders of microRNA-laden extracellular vesicles prepared by thin-film freeze-drying. Int J Pharm. 2024;651:123757.","journal-title":"Int J Pharm"},{"key":"3516_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124632","author":"K Ogawa","year":"2024","unstructured":"Ogawa K, et al. Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying. Int J Pharm. 2024. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124632.","journal-title":"Int J Pharm"},{"key":"3516_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jconrel.2023.09.031","volume":"363","author":"KP Friis","year":"2023","unstructured":"Friis KP, et al. Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA. J Control Release. 2023;363:389\u2013401.","journal-title":"J Control Release"},{"issue":"2","key":"3516_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13346-023-01402-y","volume":"14","author":"A Sarode","year":"2024","unstructured":"Sarode A, et al. Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery. Drug Deliv Transl Res. 2024;14(2):360\u201372.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"3516_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11095-025-03869-5","volume":"42","author":"A Alexeenko","year":"2025","unstructured":"Alexeenko A, Korang-Yeboah M, Tchessalov S. Critical needs and opportunities for advanced manufacturing of lyophilized injectables. Pharm Res. 2025;42(6):1059\u201364.","journal-title":"Pharm Res"},{"issue":"1","key":"3516_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41421-022-00517-9","volume":"9","author":"L Ai","year":"2023","unstructured":"Ai L, et al. Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2. Cell Discov. 2023;9(1):9.","journal-title":"Cell Discov"},{"issue":"2","key":"3516_CR15","first-page":"358","volume":"5","author":"P Zhao","year":"2020","unstructured":"Zhao P, et al. Long-term storage of lipid-like nanoparticles for mRNA delivery. Bioact Mater. 2020;5(2):358\u201363.","journal-title":"Bioact Mater"},{"issue":"12","key":"3516_CR16","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.3390\/pharmaceutics15122702","volume":"15","author":"J Anindita","year":"2023","unstructured":"Anindita J, et al. Development of a ready-to-use-type RNA vaccine carrier based on an intracellular environment-responsive lipid-like material with immune-activating vitamin E scaffolds. Pharmaceutics. 2023;15(12):2702.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3516_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41541-023-00732-9","volume":"8","author":"M Li","year":"2023","unstructured":"Li M, et al. Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine. npj Vaccines. 2023;8(1):153.","journal-title":"npj Vaccines"},{"key":"3516_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071819","author":"D Shirane","year":"2023","unstructured":"Shirane D, et al. Development of an alcohol dilution-lyophilization method for the preparation of mRNA-LNPs with improved storage stability. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15071819.","journal-title":"Pharmaceutics"},{"key":"3516_CR19","doi-asserted-by":"publisher","first-page":"120169","DOI":"10.1016\/j.ijpharm.2020.120169","volume":"594","author":"TT Mutukuri","year":"2021","unstructured":"Mutukuri TT, et al. Effects of drying method and excipient on the structure and physical stability of protein solids: freeze drying vs. spray freeze drying. Int J Pharm. 2021;594:120169.","journal-title":"Int J Pharm"},{"key":"3516_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.addr.2021.02.016","volume":"172","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Pharmaceutical protein solids: drying technology, solid-state characterization and stability. Adv Drug Deliv Rev. 2021;172:211\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"3516_CR21","doi-asserted-by":"publisher","first-page":"123688","DOI":"10.1016\/j.ijpharm.2023.123688","volume":"650","author":"K AboulFotouh","year":"2023","unstructured":"AboulFotouh K, et al. Effect of lipid composition on RNA-lipid nanoparticle properties and their sensitivity to thin-film freezing and drying. Int J Pharm. 2023;650:123688.","journal-title":"Int J Pharm"},{"key":"3516_CR22","doi-asserted-by":"publisher","first-page":"124974","DOI":"10.1016\/j.ijpharm.2024.124974","volume":"668","author":"CD Patil","year":"2025","unstructured":"Patil CD, et al. Effects of buffers on spray-freeze-dried\/lyophilized high concentration protein formulations. Int J Pharm. 2025;668:124974.","journal-title":"Int J Pharm"},{"key":"3516_CR23","doi-asserted-by":"publisher","first-page":"120942","DOI":"10.1016\/j.ijpharm.2021.120942","volume":"607","author":"TT Mutukuri","year":"2021","unstructured":"Mutukuri TT, et al. Electrostatic spray drying for monoclonal antibody formulation. Int J Pharm. 2021;607:120942.","journal-title":"Int J Pharm"},{"key":"3516_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1023\/A:1007570030368","volume":"17","author":"HR Costantino","year":"2000","unstructured":"Costantino HR, et al. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm Res. 2000;17:1374\u201382.","journal-title":"Pharm Res"},{"issue":"2","key":"3516_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tifs.2014.10.008","volume":"41","author":"SP Ishwarya","year":"2015","unstructured":"Ishwarya SP, Anandharamakrishnan C, Stapley AGF. Spray-freeze-drying: a novel process for the drying of foods and bioproducts. Trends Food Sci Technol. 2015;41(2):161\u201381.","journal-title":"Trends Food Sci Technol"},{"issue":"2","key":"3516_CR26","first-page":"163","volume":"13","author":"W Liang","year":"2018","unstructured":"Liang W, et al. Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery. Asian J Pharm Sci. 2018;13(2):163\u201372.","journal-title":"Asian J Pharm Sci"},{"issue":"1\u20132","key":"3516_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijpharm.2018.09.045","volume":"552","author":"W Liang","year":"2018","unstructured":"Liang W, et al. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation. Int J Pharm. 2018;552(1\u20132):67\u201375.","journal-title":"Int J Pharm"},{"key":"3516_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jconrel.2018.04.003","volume":"279","author":"T Okuda","year":"2018","unstructured":"Okuda T, et al. Development of spray-freeze-dried siRNA\/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity. J Control Release. 2018;279:99\u2013113.","journal-title":"J Control Release"},{"key":"3516_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.omtn.2018.07.009","volume":"12","author":"K Miwata","year":"2018","unstructured":"Miwata K, et al. Intratracheal administration of siRNA dry powder targeting vascular endothelial growth factor inhibits lung tumor growth in mice. Mol Ther Nucleic Acids. 2018;12:698\u2013706.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4678","key":"3516_CR30","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/1831802a0","volume":"183","author":"E Andrew","year":"1959","unstructured":"Andrew E, Bradbury A, Eades R. Removal of dipolar broadening of nuclear magnetic resonance spectra of solids by specimen rotation. Nature. 1959;183(4678):1802\u20133.","journal-title":"Nature"},{"issue":"2","key":"3516_CR31","first-page":"341","volume":"49","author":"W Dixon","year":"1982","unstructured":"Dixon W, et al. Total suppression of sidebands in CPMAS C-13 NMR. J Magn Reson. 1982;49(2):341\u20135.","journal-title":"J Magn Reson"},{"issue":"2","key":"3516_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1063\/1.1680061","volume":"59","author":"A Pines","year":"1973","unstructured":"Pines A, Gibby MG, Waugh J. Proton-enhanced NMR of dilute spins in solids. J Chem Phys. 1973;59(2):569\u201390.","journal-title":"J Chem Phys"},{"issue":"1","key":"3516_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/jmre.1999.1896","volume":"142","author":"B Fung","year":"2000","unstructured":"Fung B, Khitrin A, Ermolaev K. An improved broadband decoupling sequence for liquid crystals and solids. J Magn Reson. 2000;142(1):97\u2013101.","journal-title":"J Magn Reson"},{"issue":"3\u20134","key":"3516_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ssnmr.2006.06.001","volume":"30","author":"DH Barich","year":"2006","unstructured":"Barich DH, et al. 3-Methylglutaric acid as a 13C solid-state NMR standard. Solid State Nucl Magn Reson. 2006;30(3\u20134):125\u20139.","journal-title":"Solid State Nucl Magn Reson"},{"issue":"1","key":"3516_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.powtec.2006.08.019","volume":"170","author":"Z Wang","year":"2006","unstructured":"Wang Z, et al. Powder formation by atmospheric spray-freeze-drying. Powder Technol. 2006;170(1):45\u201352.","journal-title":"Powder Technol"},{"key":"3516_CR36","doi-asserted-by":"crossref","unstructured":"Bhatnagar BS, Tchessalov S, Lewis LM, Johnson R. Freeze drying of biologics. In: Encyclopedia of pharmaceutical science and technology, six volume set (Print). CRC Press; 2013. p. 1673\u20131722.","DOI":"10.1081\/E-EPT4-120050277"},{"issue":"1","key":"3516_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2015.04.053","volume":"488","author":"S Wanning","year":"2015","unstructured":"Wanning S, S\u00fcverkr\u00fcp R, Lamprecht A. Pharmaceutical spray freeze drying. Int J Pharm. 2015;488(1):136\u201353.","journal-title":"Int J Pharm"},{"key":"3516_CR38","doi-asserted-by":"publisher","first-page":"105984","DOI":"10.1016\/j.ultsonch.2022.105984","volume":"86","author":"H Naidu","year":"2022","unstructured":"Naidu H, Kahraman O, Feng H. Novel applications of ultrasonic atomization in the manufacturing of fine chemicals, pharmaceuticals, and medical devices. Ultrason Sonochem. 2022;86:105984.","journal-title":"Ultrason Sonochem"},{"issue":"1-2","key":"3516_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0005-2736(00)00251-0","volume":"1468","author":"SD Allison","year":"2000","unstructured":"Allison SD, Molina MdC, Anchordoquy TJ. Stabilization of lipid\/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta. 2000;1468(1\u20132):127\u201338.","journal-title":"Biochim Biophys Acta"},{"issue":"20","key":"3516_CR40","doi-asserted-by":"publisher","first-page":"13294","DOI":"10.1039\/C7CP01530E","volume":"19","author":"Z Shen","year":"2017","unstructured":"Shen Z, et al. Self-assembled core\u2013polyethylene glycol\u2013lipid shell nanoparticles demonstrate high stability in shear flow. Phys Chem Chem Phys. 2017;19(20):13294\u2013306.","journal-title":"Phys Chem Chem Phys"},{"key":"3516_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ejpb.2021.05.024","volume":"165","author":"E Trenkenschuh","year":"2021","unstructured":"Trenkenschuh E, Friess W. Freeze-drying of nanoparticles: how to overcome colloidal instability by formulation and process optimization. Eur J Pharm Biopharm. 2021;165:345\u201360.","journal-title":"Eur J Pharm Biopharm"},{"key":"3516_CR42","volume-title":"General principles of colloid stability and the role of surface forces","author":"T Tadros","year":"2007","unstructured":"Tadros T. General principles of colloid stability and the role of surface forces, vol. Vol. 1. Wiley Online Library; 2007."},{"issue":"7","key":"3516_CR43","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/jps.1040","volume":"90","author":"JA Searles","year":"2001","unstructured":"Searles JA, Carpenter JF, Randolph TW. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T\u2019g in pharmaceutical lyophilization. J Pharm Sci. 2001;90(7):872\u201387.","journal-title":"J Pharm Sci"},{"issue":"4","key":"3516_CR44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/jps.10334","volume":"92","author":"SD Webb","year":"2003","unstructured":"Webb SD, et al. Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-\u03b3. J Pharm Sci. 2003;92(4):715\u201329.","journal-title":"J Pharm Sci"},{"issue":"11","key":"3516_CR45","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1016\/j.xphs.2020.07.015","volume":"109","author":"M Mohammady","year":"2020","unstructured":"Mohammady M, Yousefi G. Freeze-drying of pharmaceutical and nutraceutical nanoparticles: the effects of formulation and technique parameters on nanoparticles characteristics. J Pharm Sci. 2020;109(11):3235\u201347.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3516_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejpb.2006.01.015","volume":"63","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm. 2006;63(2):87\u201394.","journal-title":"Eur J Pharm Biopharm"},{"key":"3516_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejpb.2021.10.014","volume":"169","author":"W-C Luo","year":"2021","unstructured":"Luo W-C, et al. Impact of formulation on the quality and stability of freeze-dried nanoparticles. Eur J Pharm Biopharm. 2021;169:256\u201367.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"3516_CR48","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1529\/biophysj.106.096461","volume":"92","author":"G van den Bogaart","year":"2007","unstructured":"van den Bogaart G, et al. On the decrease in lateral mobility of phospholipids by sugars. Biophys J. 2007;92(5):1598\u2013605.","journal-title":"Biophys J"},{"issue":"18","key":"3516_CR49","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.1021\/la049485l","volume":"20","author":"MA Villarreal","year":"2004","unstructured":"Villarreal MA, et al. Molecular dynamics simulation study of the interaction of trehalose with lipid membranes. Langmuir. 2004;20(18):7844\u201351.","journal-title":"Langmuir"},{"issue":"2","key":"3516_CR50","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/jz900338m","volume":"1","author":"P Sundaramurthi","year":"2010","unstructured":"Sundaramurthi P, Suryanarayanan R. Trehalose crystallization during freeze-drying: implications on lyoprotection. J Phys Chem Lett. 2010;1(2):510\u20134.","journal-title":"J Phys Chem Lett"},{"issue":"7","key":"3516_CR51","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1021\/acs.molpharmaceut.1c00189","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Understanding the impact of protein\u2013excipient interactions on physical stability of spray-dried protein solids. Mol Pharm. 2021;18(7):2657\u201368.","journal-title":"Mol Pharm"},{"issue":"7","key":"3516_CR52","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1021\/acs.molpharmaceut.3c01085","volume":"21","author":"CW Tower","year":"2024","unstructured":"Tower CW, et al. Predicting the stability of formulations containing lyophilized human serum albumin and sucrose\/trehalose using solid-state NMR spectroscopy. Mol Pharm. 2024;21(7):3163\u201372.","journal-title":"Mol Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03516-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:03:13Z","timestamp":1788984193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03516-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3516"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03516-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eric J Munson is a partial owner of Kansas Analytical Services, which provides solid-state NMR services to the pharmaceutical industry, and Spectral NMR Technologies, which offer specialized NMR equipment and testing for the non-destructive evaluation of pharmaceutical products. The results presented here are from academic work at Purdue University, and no data from either Kansas Analytical Services or Spectral NMR Technologies are presented.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"284"}}